Similar articles

• [Descriptive epidemiology of prostate cancer in Japan and Western countries].

  Wakai K. Wakai K. Nihon Rinsho. 2005 Feb;63(2):207-12. Nihon Rinsho. 2005. PMID: 15714967 Review. Japanese.
• The evolving role of familial history for prostate cancer.

  Colloca G, Venturino A. Colloca G, et al. Acta Oncol. 2011 Jan;50(1):14-24. doi: 10.3109/0284186X.2010.521191. Epub 2010 Sep 27. Acta Oncol. 2011. PMID: 20874046 Review.
• Early diagnosis of prostate cancer: the continuing debate on the impact on mortality.

  Höltl W, Lunglmayr G. Höltl W, et al. Wien Klin Wochenschr. 2005 Jul;117(13-14):440-1. doi: 10.1007/s00508-005-0398-8. Wien Klin Wochenschr. 2005. PMID: 16091868 No abstract available.
• Prostate cancer and prostate-specific antigen (PSA) screening in Austria.

  Vutuc C, Schernhammer ES, Haidinger G, Waldhör T. Vutuc C, et al. Wien Klin Wochenschr. 2005 Jul;117(13-14):457-61. doi: 10.1007/s00508-005-0395-y. Wien Klin Wochenschr. 2005. PMID: 16091872
• Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.

  Bratt O, Garmo H, Adolfsson J, Bill-Axelson A, Holmberg L, Lambe M, Stattin P. Bratt O, et al. J Natl Cancer Inst. 2010 Sep 8;102(17):1336-43. doi: 10.1093/jnci/djq265. Epub 2010 Aug 19. J Natl Cancer Inst. 2010. PMID: 20724726